納菲制藥
Nasal-Phyto
Categories Of News
Nasal-Phyto Pharmaceuticals has successfully obtained dual certifications
Author：adminTime：2025/5/9 22:23:40Click：0
Nasal-Phyto Pharmaceuticals has successfully obtained dual certifications····
The first new mechanism antidepressant in 30 years! Johnson & Johnson Spravato Nasal Spray Submits N
Author：adminTime：2019/12/5 21:15:38Click：2027
October 10, 2019 / Bio Valley BIOON /-Janssen Pharmaceuticals, a Johnson & Johnson subsidiary, recently announced that it has submitted a new supplement to the US Food and Drug Administration (FDA) depression drug Spravato (esketamine) CIII nasal spr····
New major depression drug launched! FDA approves new nasal spray formulation with rapid onset of act
Author：adminTime：2019/12/5 21:14:04Click：2043
On March 5, local time, the FDA issued a statement saying it agreed to approve the launch of a new nasal spray drug, Spravato (Esketamine), for the treatment of resistant depression. This is the first major depression treatment to enter the US market····
Nano-gold nasal spray can provide fast and safe drug access to the brain
Author：adminTime：2019/11/28 9:27:35Click：2064
How to cross the blood-brain barrier is a challenge for drug developers. Now, after a new drug delivery test on locusts, a team of engineers showed how aerosol nasal sprays containing nanogold provide a non-invasive and fast way to deliver drugs to t····
Butorphin tartrate nasal spray
Author：adminTime：2019/11/28 8:55:12Click：1891
Butorphin tartrate nasal spray, a quantitative spray to the nasal cavity for viscous administration, is an aqueous solution of butorphin tartrate. Each bottle of Butorphin tartrate nasal spray contains 2.5 ml of 10 mg / ml Butorphin tartrate solution····